Stamford, CT -- (SBWIRE) -- 01/29/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Recon Technology, Ltd. (NASDAQ:RCON), Lantronix Inc (NASDAQ:LTRX), SemiLEDs Corporation (NASDAQ:LEDS), BG Medicine, Inc. (NASDAQ:BGMD)
Recon Technology, Ltd. (NASDAQ:RCON) opened the session at $3.80, trading in a range of $3.80 - $5.06,. The stock showed a positive performance of +38.16% in the last trading session from its previous close of $3.59 and closed at $4.96. The stock traded on a volume of 1.66 million shares and the average volume of the stock remained 92,080 shares. Recon Technology, Ltd is a limited liability company. The Company provides hardware, software, and on-site services to companies in the petroleum mining and extraction industry in People's Republic of China. It provides services designed to automate and enhance the extraction of petroleum. It controls by contract the PRC companies of Beijing BHD Petroleum Technology Co., Ltd., Nanjing Recon Technology Co., Ltd. and Jining ENI Energy Technology Co., Ltd. (collectively, the Domestic Companies).
For How Long RCON will Fight for Profitability? Read This Trend Analysis report
Lantronix Inc (NASDAQ:LTRX) traded 1.05 million shares in the last business day while the average volume of the stock remained 200,239 shares. The stock showed a positive movement of +23.56% to end at $2.57. The 52 week range of the stock remained $1.31 - $3.03. Lantronix, Inc. designs, develops, markets and sells products that make it possible to access, manage, control and configure electronic products over the Internet or other networks. Its device management solutions address applications that manage equipment at data centers and remote branch offices to provide management for information technology (IT) systems. Its network connectivity solutions are sold into market segments, including healthcare, industrial, security, energy, information technology (IT), data centers, transportation, government and others.
For How Long LTRX’s Gloss will Attract Investors? Find out via this report
SemiLEDs Corporation (NASDAQ:LEDS) reported 1.13 million shares were exchanged during the last trade, while the average volume is about 589,490 shares. The stock escalated +22.22% and finished the day at $1.44. The beta of the stock is recorded at 1.52. SemiLEDs Corporation develops, manufactures, and sells light emitting diode (LED) chips and LED components. Its products are used primarily for general lighting applications, including street lights and commercial, industrial, and residential lighting, as well as specialty industrial applications, such as ultraviolet (UV) applications, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, and architectural lighting applications.
For How Long LEDS’s Gloss will Attract Investors? Find out via this report
BG Medicine, Inc. (NASDAQ:BGMD) shares rose, +20.87 percent from its previous close of $1.15 to close at $1.39. Traded with volume of 8.86 million shares in the prior session and the average volume of the stock remained 1.98 million shares. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States.
Why Should Investors Buy BGMD After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)